Developing a Sustainable Consumer Clearinghouse for Translational Depression and
为转化型抑郁症和抑郁症开发可持续的消费者信息交换所
基本信息
- 批准号:8006089
- 负责人:
- 金额:$ 90.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-15 至 2013-06-14
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseBehavioralBipolar DepressionBusinessesClinicCommunicationCommunitiesCommunity Health EducationConsumer AdvocacyConsumer ParticipationCountryDatabasesDevelopmentDiseaseEducationEducation and OutreachEffectivenessEnsureEquipment and supply inventoriesEvaluationEvaluation ResearchEventFocus GroupsFrightFutureHealth ServicesHealthcareHotlinesHousingInformed ConsentInstitutionInternetInterviewLinkMarketingMental DepressionMichiganModelingMood DisordersMoodsOhioParkinson DiseaseParticipantPostdoctoral FellowPrevalencePrimary Health CareProviderRegistriesResearchResearch InfrastructureResearch PersonnelResourcesSafetySchoolsScienceSocial NetworkSpecialistStigmataSurveysTrainingTranslational ResearchUniversitiesVoiceWomanbasedepression educationeducation planningempoweredinteractive multimediainterestmultidisciplinaryoutreachprogramspublic health relevanceresearch studysocial networking websitesocial stigmasuccessweb site
项目摘要
DESCRIPTION (provided by applicant): Translational research is the cornerstone of health care advances. However, facilitating communication between research participants or consumers and investigators has been a challenge for decades. Divergent consumer and investigator perspectives have led to failed research studies due to lack of research participants, misunderstandings, stigma, and even fear of research misuse and abuse among consumers. These challenges are unique for different disorders, and may be exacerbated in depression and bipolar research, due in part to the inherent behavioral constraints imposed by depression, bipolar, and other mood disorders, difficulty in reaching consumers in specific disease states, the prevalence of co-occurring disorders, and the few community or public resources currently available to support these connections. The proposed program aims to develop a groundbreaking, sustainable program for depression, bipolar and mood research by creating a Consumer Depression-Bipolar Research Clearinghouse. The Clearinghouse would provide researchers the opportunity to link directly with consumers interested in participating in translational depression research, and would provide consumers the opportunity to have a voice in the priorities, direction and evaluation of this research. The Clearinghouse will build upon a pre-existing partnership among one of the nation's leading consumer advocacy groups (Depression and Bipolar Support Alliance), the nation's inaugural Comprehensive Depression Center (University of Michigan Comprehensive Depression Center), and in the future, the National Network of Depression Centers. It will employ social networking strategies, community engagement and personalized outreach to achieve its aims. The program will be launched regionally in Michigan and northern Ohio, evaluated for effectiveness, and then made sustainable through expansion to national partners.
PUBLIC HEALTH RELEVANCE: The proposed program aims to develop a sustainable program to promote depression, bipolar and mood research. The Consumer Depression-Bipolar Research Clearinghouse would provide researchers the opportunity to identify consumers interested in participating in translational depression research, and would provide consumers the opportunity to have a voice in the priorities, direction and evaluation of depression research.
描述(由申请人提供):转化研究是医疗保健进步的基石。然而,促进研究参与者或消费者与研究人员之间的沟通几十年来一直是一个挑战。由于缺乏研究参与者、误解、污名化,甚至消费者对研究误用和滥用的恐惧,消费者和研究者观点的分歧导致研究失败。这些挑战对于不同的疾病是独特的,并且在抑郁症和双相情感障碍的研究中可能会加剧,部分原因是抑郁症、双相情感障碍和其他情绪障碍所施加的固有行为限制,在特定疾病状态下接触消费者的困难,共同发生的疾病的流行,以及目前可用于支持这些联系的社区或公共资源很少。拟议的项目旨在通过创建消费者抑郁症-双相情感障碍研究信息中心,为抑郁症、双相情感障碍和情绪研究开发一个开创性的、可持续的项目。信息交换中心将为研究人员提供机会,与有兴趣参与转化抑郁症研究的消费者直接联系,并为消费者提供机会,对这项研究的优先事项、方向和评估发表意见。信息交换中心将建立在一个已经存在的伙伴关系之上,这个伙伴关系包括全国领先的消费者权益组织之一(抑郁症和双相情感障碍支持联盟),全国首个综合抑郁症中心(密歇根大学综合抑郁症中心),以及未来的全国抑郁症中心网络。它将采用社交网络策略、社区参与和个性化外展来实现其目标。该计划将在密歇根州和俄亥俄州北部地区启动,评估其有效性,然后通过扩大到国家合作伙伴使其可持续发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patricia J Deldin其他文献
Patricia J Deldin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 90.53万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 90.53万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 90.53万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 90.53万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 90.53万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 90.53万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 90.53万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 90.53万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 90.53万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 90.53万 - 项目类别: